Evaluating a Digital Cognitive Training Intervention in Adults With ADHD

N/ANot Yet RecruitingNCT07050225

McMaster University52 enrolled

Overview

The goal of this clinical trial is to evaluate whether a digital cognitive training program can reduce symptoms of ADHD, improve executive functioning, and decrease problematic internet use in adults aged 18-65 with a diagnosis of moderate to severe ADHD. The main questions it aims to answer are: Can digital cognitive training improve executive function, and ADHD symptoms in adults with ADHD? Does digital cognitive training reduce problematic internet use in this population? Researchers will compare the digital cognitive training intervention group to a non-cognitive training digital platform to see if the training leads to greater improvements in cognitive and behavioral outcomes. Participants will: Complete an 11-week digital cognitive training program (3, 1-hour sessions/week) or placebo intervention (3, 1-hour sessions/week) Attend baseline, midpoint, and post-intervention assessments Participate in weekly check-ins to monitor engagement and tolerability

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

ADHD

Interventions

This digital cognitive training program uses gamified tasks in order to enhance cognitive skills in an engaging manner using machine learning AI algorithms to target the intervention to individual cognitive skill deficits. It consists of personalized gamified cognitive tasks that target individual cognitive deficits associated with ADHD including attention, impulsivity, working memory, and cognitive flexibility.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Participants must provide informed consent and agree to comply with study protocols for the duration of the study. * Participants must be fluent in speaking and reading English and able to complete rating scales and assessments. * Participants must be adults aged 18-65 years. * Participants must have a clinical diagnosis of ADHD based on DSM-5 Criteria, as confirmed by the Mini Neuropsychiatric interview. * Participants being treated with pharmacotherapy must be stable and on a consistent dose for at least 6 weeks prior to study entry. * Participants must have access to a computer capable of running the cognitive training platform. * Participants must be comfortable operating a computer and be able to log on to the platform without assistance. Exclusion Criteria: * Exclude individuals who meet DSM-5 criteria for psychiatric conditions such as borderline personality disorder, schizophrenia, severe depression, or other psychotic disorders as well as neurological conditions such as epilepsy, dementia, and amnesia, that may interfere with cognitive training. * Exclude participants with active substance use disorders. * Exclude participants receiving behavioral therapy or undergoing similar cognitive training programs for ADHD and/or PIU. * Exclude individuals with severe visual, auditory, or motor impairments that affect the ability to perform the digital cognitive training intervention. * Exclude participants who are uncomfortable using applications or required technology. * Exclude participants who have changed their treatment regimen in the last 6 weeks. * Exclude participants who are not fluent in English.

Outcomes

Primary Outcomes

Number of participants who prematurely withdraw from the study protocol

Tolerability of the digital cognitive training intervention will be assessed by calculating the number of participants who discontinue participation before completing the full 11-week study protocol. Premature withdrawal will be defined as any participant who discontinues the intervention and/or does not complete post-treatment assessments.